Molecular Assemblies to Participate in Cowen’s 43rd Annual Health Care Conference

SAN DIEGO, February 22, 2023 – Molecular Assemblies, Inc., a pioneer in the field of enzymatic DNA synthesis, today announced the management team will be available for 1×1 meetings at Cowen’s 43rd Annual Health Care Conference taking place March 6 to 8 in Boston. 

Cowen’s 43rd Annual Health Care Conference

Dates: Monday, March 6 to Wednesday, March 8  

Location: Boston Marriott Copley Place

To schedule a meeting with Molecular Assemblies, please email

About Molecular Assemblies

Molecular Assemblies, Inc. is a private life sciences company developing an enzymatic DNA synthesis technology designed to power the next generation of DNA-based products. The company’s patented Fully Enzymatic Synthesis™ (or FES™), based on making DNA the way nature makes DNA, produces long, high quality, sequence-specific DNA reliably, affordably, and sustainably. FES™ technology will enable the reading and writing of DNA for many industries, including industrial synthetic biology and precision medicine, as well as emerging applications of DNA for data information storage, nanomachines, and bio-based electronics. Molecular Assemblies is headquartered in San Diego. 


Company: Ben Johnson, Director of Product Marketing,  

Media: Jessica Yingling, Ph.D., Little Dog Communications Inc.,,  +1.858.344.8091